Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance Detection and Clinical Implications in a Selected Cohort in New Zealand.

Anderson T, Coughlan E, Werno A.

J Clin Microbiol. 2017 Nov;55(11):3242-3248. doi: 10.1128/JCM.01087-17. Epub 2017 Sep 6.

PMID:
28878004
2.

Cost-benefit analysis of Chlamydia trachomatis screening in pregnant women in a high burden setting in the United States.

Ditkowsky J, Shah KH, Hammerschlag MR, Kohlhoff S, Smith-Norowitz TA.

BMC Infect Dis. 2017 Feb 18;17(1):155. doi: 10.1186/s12879-017-2248-5.

3.

The optimal treatment of an infectious disease with two strains.

Rowthorn R, Walther S.

J Math Biol. 2017 Jun;74(7):1753-1791. doi: 10.1007/s00285-016-1074-5. Epub 2016 Nov 11.

4.

Azithromycin Treatment Failure for Chlamydia trachomatis Among Heterosexual Men With Nongonococcal Urethritis.

Kissinger PJ, White S, Manhart LE, Schwebke J, Taylor SN, Mena L, Khosropour CM, Wilcox L, Schmidt N, Martin DH.

Sex Transm Dis. 2016 Oct;43(10):599-602. doi: 10.1097/OLQ.0000000000000489.

5.

Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature.

Chan PA, Robinette A, Montgomery M, Almonte A, Cu-Uvin S, Lonks JR, Chapin KC, Kojic EM, Hardy EJ.

Infect Dis Obstet Gynecol. 2016;2016:5758387. doi: 10.1155/2016/5758387. Epub 2016 Jun 5. Review.

7.

Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection.

Geisler WM, Uniyal A, Lee JY, Lensing SY, Johnson S, Perry RC, Kadrnka CM, Kerndt PR.

N Engl J Med. 2015 Dec 24;373(26):2512-21. doi: 10.1056/NEJMoa1502599.

8.

Treatment challenges for urogenital and anorectal Chlamydia trachomatis.

Kong FY, Hocking JS.

BMC Infect Dis. 2015 Jul 29;15:293. doi: 10.1186/s12879-015-1030-9. Review.

9.
10.
11.

Chlamydia (uncomplicated, genital).

Crofts M, Horner P.

BMJ Clin Evid. 2015 Apr 16;2015. pii: 1607.

12.

Enrofloxacin and macrolides alone or in combination with rifampicin as antimicrobial treatment in a bovine model of acute Chlamydia psittaci infection.

Prohl A, Lohr M, Ostermann C, Liebler-Tenorio E, Berndt A, Schroedl W, Rothe M, Schubert E, Sachse K, Reinhold P.

PLoS One. 2015 Mar 13;10(3):e0119736. doi: 10.1371/journal.pone.0119736. eCollection 2015.

13.

Recent advances in understanding and managing Chlamydia trachomatis infections.

Marrazzo J, Suchland R.

F1000Prime Rep. 2014 Dec 1;6:120. doi: 10.12703/P6-120. eCollection 2014. Review.

14.

Chlamydia trachomatis Infection: Screening and Management.

Keegan MB, Diedrich JT, Peipert JF.

J Clin Outcomes Manag. 2014 Jan;21(1):30-38.

15.

Estimating age-dependent per-encounter chlamydia trachomatis acquisition risk via a Markov-based state-transition model.

Teng Y, Kong N, Tu W.

J Clin Bioinforma. 2014 Apr 25;4:7. doi: 10.1186/2043-9113-4-7. eCollection 2014.

16.

Randomized, double-blind, multicenter safety and efficacy study of rifalazil compared with azithromycin for treatment of uncomplicated genital Chlamydia trachomatis infection in women.

Geisler WM, Pascual ML, Mathew J, Koltun WD, Morgan F, Batteiger BE, Mayes A, Tao S, Hurwitz SJ, Sayada C, Schinazi RF.

Antimicrob Agents Chemother. 2014 Jul;58(7):4014-9. doi: 10.1128/AAC.02521-14. Epub 2014 May 5.

17.

A cross-sectional study of Mycoplasma genitalium infection and correlates in women undergoing population-based screening or clinic-based testing for Chlamydia infection in London.

Svenstrup HF, Dave SS, Carder C, Grant P, Morris-Jones S, Kidd M, Stephenson JM.

BMJ Open. 2014 Feb 6;4(2):e003947. doi: 10.1136/bmjopen-2013-003947.

18.

Comparing azithromycin and doxycycline for the treatment of rectal chlamydial infection: a retrospective cohort study.

Khosropour CM, Dombrowski JC, Barbee LA, Manhart LE, Golden MR.

Sex Transm Dis. 2014 Feb;41(2):79-85. doi: 10.1097/OLQ.0000000000000088.

19.

Detection of anorectal and cervicovaginal Chlamydia trachomatis infections following azithromycin treatment: prospective cohort study with multiple time-sequential measures of rRNA, DNA, quantitative load and symptoms.

Dukers-Muijrers NH, Speksnijder AG, Morré SA, Wolffs PF, van der Sande MA, Brink AA, van den Broek IV, Werner MI, Hoebe CJ.

PLoS One. 2013 Nov 20;8(11):e81236. doi: 10.1371/journal.pone.0081236. eCollection 2013.

20.

Suboptimal adherence to doxycycline and treatment outcomes among men with non-gonococcal urethritis: a prospective cohort study.

Khosropour CM, Manhart LE, Colombara DV, Gillespie CW, Lowens MS, Totten PA, Golden MR, Simoni J.

Sex Transm Infect. 2014 Feb;90(1):3-7. doi: 10.1136/sextrans-2013-051174. Epub 2013 Oct 8.

Supplemental Content

Support Center